Aligos Therapeutics (ALGS)
(Real Time Quote from BATS)
$19.19 USD
-0.27 (-1.39%)
Updated Nov 15, 2024 02:48 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 29% (72 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.38 | 9.99 |
Current Quarter Estimate | -2.50 | 2.15 | 63.00 |
Year Ago Quarter Estimate | -5.50 | 1.53 | 52.25 |
Next Quarter Estimate | -2.76 | 2.94 | 66.00 |
Next Year Estimate | -11.92 | 21.30 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 69.53 | 17.70 | 15.67 |
Next Year | -15.06 | 9.40 | 11.34 |
Last 5 Years | NA | 4.00 | 8.10 |
Next 5 Years | NA | 21.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -3.92 |
Price/Book (MRQ) | 1.29 | 2.11 |
Price/Cash Flow (MRFY) | NA | 15.64 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -1,283.19% | -60.49% |
Return on Equity (TTM) | -114.34% | -44.78% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.